Page last updated: 2024-09-03

kallidin, des-arg(10)- and enalapril

kallidin, des-arg(10)- has been researched along with enalapril in 1 studies

Compound Research Comparison

Studies
(kallidin, des-arg(10)-)
Trials
(kallidin, des-arg(10)-)
Recent Studies (post-2010)
(kallidin, des-arg(10)-)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
804176,3111,924859

Protein Interaction Comparison

ProteinTaxonomykallidin, des-arg(10)- (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cruden, NL; Fox, KA; Ludlam, CA; Megson, I; Newby, DE; Tse, GH1

Trials

1 trial(s) available for kallidin, des-arg(10)- and enalapril

ArticleYear
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:4

    Topics: Adolescent; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin B1 Receptor Antagonists; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Forearm; Heart Failure; Humans; In Vitro Techniques; Kallidin; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pregnancy; Receptor, Bradykinin B1; Regional Blood Flow; Tissue Plasminogen Activator; Umbilical Veins; Vasoconstriction

2005